Pulmonx Corporation

Healthcare

NASDAQ:LUNG · NASDAQ Global Select

Market Cap $52.80M Beta 0.28 P/E (TTM) -1.0

$1.28 +3.60%

+$0.05 today

52W Low $1.13High $3.88

Vol 0.62M · Avg 0.44M

EPS (TTM) -$1.27Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-50.19%

Period High

$3.78

Period Low

$1.17

Latest

$1.28

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Relmada Therapeutics, Inc.

NASDAQ:RLMD

$485.84M

Edap Tms S.a.

EDAP

$178.23M

Assertio Holdings, Inc.

NASDAQ:ASRT

$151.86M

Immunic, Inc.

NASDAQ:IMUX

$139.22M

Vaxart, Inc.

NASDAQ:VXRT

$135.55M

Hyperfine, Inc.

NASDAQ:HYPR

$134.50M

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

$61.06M

TScan Therapeutics, Inc.

NASDAQ:TCRX

$56.19M

Acrivon Therapeutics, Inc. Common Stock

ACRV

$48.91M

TELA Bio, Inc.

TELA

$35.81M

What is the latest LUNG filing?

The latest filing shown is 4 dated Jun 9, 2026.

How many recent filings does LUNG have?

Intrinsic Alpha currently shows 20 recent filings for LUNG.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.